{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10(4)"],"submitter":["Wei A"],"journal":["Blood advances"],"pagination":["987-998"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12914422"],"repository":["biostudies-literature"],"pubmed_title":["Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy"],"pmcid":["PMC12914422"],"pubmed_authors":["Lee S","Champion R","DiNardo C","Lin T","Jiang Q","Ivanov V","Kim I","Pagoni M","Wang J","Liu Z","Ting S","Tiong I","Strickland S","Enjeti A","Panayiotidis P","Yamauchi T","Fiedler W","Bergeron J","Wei A","Mendes W","Laribi K","Sun Y","Savona M","Hou J","Montesinos P","Novak J","Roboz G","Popovic R","Chyla B"],"additional_accession":[]},"is_claimable":false,"name":"Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Nov","modification":"2026-07-16T06:34:47.599Z","creation":"2026-07-09T10:39:27.995Z"},"accession":"S-EPMC12914422","cross_references":{}}